Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Oct2022, Vol. 10 Issue 10, p985-996, 12p
- Subject
COVID-19 treatment COVID-19 INTRAMUSCULAR injections ANTIGEN analysis COVID-19 vaccines - Language
- ISSN
- 22132600